Axiora Medical
Premium surgical tools and implants engineered to meet international clinical protocols and OEM specifications.
The global orthopedics market has witnessed a paradigm shift in lumbar and cervical spinal fusion modalities. Interbody fusion cages, designed to restore disc height, decompress neural elements, and stabilize segment motions, are critical components in treating degenerative disc diseases (DDD), spondylolisthesis, and spinal deformities. Over the last decade, materials such as polyetheretherketone (PEEK) dominated the landscape due to their radiolucency and elastic modulus close to human bone. However, PEEK’s inherently bioinert nature often results in fibrous encapsulation rather than true direct bone-to-implant contact.
Today, the industry is experiencing a massive resurgence in titanium biomaterials, driven by advances in surface modification and additive manufacturing. Modern medical-grade titanium alloys (predominantly Ti-6Al-4V ELI) manufactured with micro-rough surfaces or 3D-printed porous structures show superior osteoconduction and osseointegration properties. These engineering leaps allow titanium cages to achieve rapid bone-ingrowth directly into the implant matrix, minimizing the risk of cage migration, subsidence, and pseudarthrosis.
Electron Beam Melting (EBM) and Selective Laser Melting (SLM) enable the design of trabecular structures that mimic natural cancellous bone. This interconnected porosity optimizes capillary action and cellular infiltration, accelerating fusion.
By engineering specific lattice structures within titanium interbody devices, manufacturers can reduce the structural stiffness of the cage to align closer to the Young's modulus of cortical and trabecular bone, thereby preventing stress shielding.
Chemical etching, anodization, and titanium plasma spraying (TPS) create nano-textured surfaces. These topography modifications improve the initial protein adsorption and trigger osteogenesis pathway signaling for faster healing.
For international medical device distributors, orthopedic brand owners, and hospital networks, importing titanium interbody cages from China requires navigating complex quality systems. The medical device industry is governed under strict YMYL (Your Money or Your Life) standards, meaning clinical efficacy, mechanical durability, and biological safety are paramount. Sourcing teams prioritize partners who not only offer cost-efficiency but possess comprehensive documentation packages to clear national registries (such as EU MDR, US FDA 510(k), and local SFDA certifications).
Key indicators of supplier competency include full material traceability (beginning with certified medical-grade titanium bar stock raw materials), ISO 13485 quality system compliance, validated cleanroom sterile packaging procedures, and dynamic fatigue testing data (ASTM F2077 / ASTM F2267) which assess compression, shear, and subsidence benchmarks under simulated physiological loads.
Years of Orthopedic Industry Expertise
Advanced Production & Cleanroom Space
Professional R&D and Biomedical Engineers
Trusted Global Supply Chain Partners
The manufacturing architecture of premium spine implants has shifted from labor-intensive setups to highly automated "Factory 4.0" systems. China's industrial clusters for medical devices, particularly in areas like Jiangsu and Zhejiang, offer unparalleled vertical integration. From high-grade raw titanium processing to Swiss-type longitudinal cutting, multi-axis CNC milling, electrochemical polishing, ultrasonic clean validation, and cleanroom sterile packaging—every step of the value chain is optimized for speed and repeatability.
At Axiora Medical Technology, we leverage advanced machinery to eliminate human error. Automated inspection systems paired with 3D Coordinate Measuring Machines (CMM) ensure that dimensions and tolerances are held within micron levels. By maintaining absolute control over the production parameters, we help overseas clients mitigate supply chain risks, offering stable lead times and competitive cost structures without sacrificing regulatory safety protocols.
Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery.
Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.
| Item / Parameter | Operational Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand Labeling | Axiora |
| Official Portal | www.axioraortho.com |
| Established Year | 2017 |
| Factory Infrastructure | 18,600 m² (Equipped with Class 100,000 Cleanrooms) |
| Annual Export Volume | USD 26 Million |
| Export Experience | 8 Years |
| Industry Tenure | 15 Years |
| Quality Inspection protocols | 100% Finished Product Inspection & Incoming Material Inspection |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Quality Control Staff | 48 Dedicated Specialists |
| Core Business Nature | Manufacturer & Exporter (OEM/ODM Solutions) |
| Primary Target Markets | Europe, North America, Middle East, Southeast Asia, South America |
| Supply Chain Network | 1,120 Qualified Partners |
| Client Demographics | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Scope | Logo Printing, Private Label, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing |
| New Product Launches (YoY) | 126 Products Released Last Year |
| Research & Development Force | 86 R&D Engineers |
Under strict adherence to ISO 13485 standards, our step-by-step production flow ensures extreme dimensional accuracy and cleanroom aseptic validation.
Surgical access strategies vary based on the patient's pathology, the spinal level, and the surgeon’s preference. A high-performing titanium interbody cage manufacturer must support multiple surgical approach geometries to accommodate diverse medical preferences globally:
Axiora supports these surgical variations by offering optimized titanium alloy designs with anatomical sizing options. Our cages feature wide bone graft windows, maximize surface contact area to minimize subsidence, and include self-retaining teeth to prevent implant displacement post-insertion.
Get clear answers regarding materials, manufacturing standards, customization (OEM/ODM), and international supply chains.
Our comprehensive portfolio extends to trauma plates, joint prostheses, mini-power drills, and arthroscopic surgical tools.